| 2D Structure | |
| CID | 102086511 |
| IUPAC Name | (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-6-[(3R,6R)-6-[(3S,8S,9R,10R,11R,13R,14S,17R)-3,11-dihydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxy-2-methylheptan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
| InChI | InChI=1S/C42H72O14/c1-20(21-15-16-40(6)26-12-10-22-23(11-13-27(44)38(22,2)3)42(26,8)28(45)17-41(21,40)7)9-14-29(39(4,5)52)56-37-35(51)33(49)31(47)25(55-37)19-53-36-34(50)32(48)30(46)24(18-43)54-36/h10,20-21,23-37,43-52H,9,11-19H2,1-8H3/t20-,21-,23-,24-,25-,26+,27+,28-,29-,30-,31-,32+,33+,34-,35-,36-,37+,40+,41-,42+/m1/s1 |
| InChI Key | NWPTUAQJIALPLJ-NCHDIWMLSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C42H72O14 |
| Molecular Weight | 801.0 |
| synonyms | ['Mogroside IIA1', '88901-44-4', 'mogroside II A1', 'Mogroside II-A1', 'Mogroside II', '87ES958MJC', 'UNII-87ES958MJC', '(3beta,9beta,10alpha,11alpha,24R)-3,11,25-Trihydroxy-9-methyl-19-norlanost-5-en-24-yl 6-o-beta-D-glucopyranosyl-beta-D-glucopyranoside', 'beta-D-Glucopyranoside, (3beta,9beta,10alpha,11alpha,24R)-3,11,25-trihydroxy-9-methyl-19-norlanost-5-en-24-yl 6-o-beta-D-glucopyranosyl-', '(2R,3R,4S,5S,6R)-2-(((2R,3S,4S,5R,6S)-6-((1R,4R)-4-((3S,8S,9R,10R,11R,13R,14S,17R)-3,11-DIHYDROXY-4,4,9,13,14-PENTAMETHYL-2,3,7,8,10,11,12,15,16,17-DECAHYDRO-1H-CYCLOPENTA(A)PHENANTHREN-17-YL)-1-(1-HYDROXY-1-METHYL-ETHYL)PENTOXY)-3,4,5-TRIHYDROXY-TETRAHYDROPYRAN-2-YL)METHOXY)-6-(HYDROXYMETHYL)TETRAHYDROPYRAN-3,4,5-TRIOL', '(2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-6-[(1R,4R)-4-[(3S,8S,9R,10R,11R,13R,14S,17R)-3,11-dihydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-(1-hydroxy-1-methyl-ethyl)pentoxy]-3,4,5-trihydroxy-tetrahydropyran-2-yl]methoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol', 'orb1297279', 'SCHEMBL29421722', 'CHEBI:232043', 'M2-A1', 'HY-N6855', 'AKOS040760559', 'EBC-615770', '(2S,3R,4S,5S,6R)-2-{[(3R,6R)-6-[(1R,3aS,3bS,7S,9aR,9bR,10R,11aR)-7,10-dihydroxy-3a,6,6,9b,11a-pentamethyl-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-hydroxy-2-methylheptan-3-yl]oxy}-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol', 'DA-65582', 'MS-31476', 'CS-0100284', '(1S,4R,24R)-1,11alpha,25-trihydroxy-9alpha,10,14-trimethyl-8beta-4,9-cyclo-9,10-secocholest-5-en-24-yl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside', '(2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-6-[(3R,6R)-6-[(3S,8S,9R,10R,11R,13R,14S,17R)-3,11-dihydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxy-2-methylheptan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol', '(2S,3R,4S,5S,6R)-2-(((3R,6R)-6-((3S,8S,9R,10R,11R,13R,14S,17R)-3,11-Dihydroxy-4,4,9,13,14-pentamethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxy-2-methylheptan-3-yl)oxy)-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3,4,5-triol', '(3.BETA.,9.BETA.,10.ALPHA.,11.ALPHA.,24R)-3,11,25-TRIHYDROXY-9-METHYL-19-NORLANOST-5-EN-24-YL 6-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSIDE', '.BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,9.BETA.,10.ALPHA.,11.ALPHA.,24R)-3,11,25-TRIHYDROXY-9-METHYL-19-NORLANOST-5-EN-24-YL 6-O-.BETA.-D-GLUCOPYRANOSYL-'] |
From Pubchem